Skip to main content

Table 1 Treatment characteristics: treatment approach, number of treated tumors, 90Y administered activity, the percentage of lung shunt fraction, tumor to non-tumor liver activity concentration ratio, and volumes for individual tumors (average ± SD), aggregated tumoral liver, target normal liver, and whole normal liver

From: Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

Patient Treatment approach Number of tumors 90Y Activity (GBq) LSF (%) TNR \( {V}_{T_i} \) (mL) VTL (mL) \( {V}_{N{L}_t} \) (mL) VNLw (mL)
1 Whole-liver 4 1.4 6.1 1.0 143 ± 155 573 1875 1785
2 Lobar 2 1.3 1.4 0.6 2 ± 1 4 789 1235
3 Lobar 1 1.2 10.1 0.8 12 12 969 1509
4 Whole-liver 50 1.8 4.0 1.2 15 ± 33 735 2277 2277
5 Lobar 3 0.6 10.7 1.2 6 ± 1 18 410 1434
6 Lobar 1 0.5 6.6 0.6 93 93 932 1551
7 Whole-liver 9 0.9 1.8 1.7 6 ± 6 50 1176 1176
8 Lobar 1 1.1 9.0 2.3 282 282 982 1577
9 Lobar 2 1 3.9 2.3 13 ± 6 26 753 1240
10 Lobar 4 0.9 2.2 1.5 10 ± 5 42 887 1725
11 Whole-liver 15 1.6 5.3 2.2 12 ± 17 177 1605 1605
12 Segmental 2 1 4.1 1.4 14 ± 1 29 472 1205
13 Lobar 1 1.8 3.6 1.2 130 129 1003 1561
14 Whole-liver 6 1.3 5.8 0.7 82 ± 53 493 1373 1373